Akso Health Group
NASDAQ:AHG
Cash Flow Statement
Cash Flow Statement
Akso Health Group
| Sep-2016 | Mar-2017 | Jun-2017 | Mar-2018 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
6
|
9
|
16
|
66
|
1
|
(13)
|
(17)
|
(9)
|
(7)
|
(135)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Change in Deffered Taxes |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(31)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
2
|
0
|
11
|
14
|
8
|
6
|
162
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
(1)
|
5
|
20
|
(2)
|
(1)
|
2
|
2
|
(3)
|
3
|
|
| Cash from Operating Activities |
5
N/A
|
8
+79%
|
21
+160%
|
88
+312%
|
(1)
N/A
|
(3)
-144%
|
(2)
+48%
|
1
N/A
|
(4)
N/A
|
1
N/A
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
(27)
|
20
|
18
|
(0)
|
(55)
|
(113)
|
(106)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-53%
|
(0)
-10%
|
(28)
-8 531%
|
20
N/A
|
18
-8%
|
(0)
N/A
|
(55)
-11 543%
|
(113)
-106%
|
(106)
+6%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
3
|
0
|
0
|
43
|
0
|
0
|
0
|
0
|
63
|
196
|
|
| Net Issuance of Debt |
(2)
|
(6)
|
(5)
|
0
|
(28)
|
(28)
|
(0)
|
(8)
|
(3)
|
0
|
|
| Other |
5
|
10
|
8
|
4
|
0
|
0
|
0
|
139
|
202
|
0
|
|
| Cash from Financing Activities |
6
N/A
|
4
-31%
|
3
-34%
|
48
+1 591%
|
(28)
N/A
|
(28)
+0%
|
(0)
+100%
|
132
N/A
|
199
+51%
|
196
-1%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
(1)
|
(1)
|
(0)
|
6
|
(3)
|
(0)
|
3
|
(1)
|
(1)
|
(1)
|
|
| Net Change in Cash |
10
N/A
|
11
+14%
|
24
+107%
|
113
+379%
|
(12)
N/A
|
(13)
-7%
|
1
N/A
|
77
+13 781%
|
81
+5%
|
90
+11%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
4
N/A
|
8
+80%
|
21
+165%
|
87
+316%
|
(1)
N/A
|
(3)
-144%
|
(2)
+48%
|
1
N/A
|
(4)
N/A
|
1
N/A
|
|